{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:35:31Z","timestamp":1781526931309,"version":"3.54.1"},"reference-count":62,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Light-chain amyloidosis (AL) is a disease of protean manifestations due to a wide spectrum of organs that can be affected. The disorder is caused by the deposition of an extracellular amorphous material, the amyloid, which is produced by malignant plasma cells. The latter usually reside in the bone marrow; plasma cell infiltration is often low, in sharp contrast to what we observe in multiple myeloma. The disease may run below the physician\u2019s radar for a while before clinical suspicion is raised and targeted tests are performed. In this short review, we try to answer most of the questions that a practicing physician may ask in a relative clinical setting. The text is formed as a series of reader-friendly questions that cover the subject of AL amyloidosis from history to current therapy.<\/jats:p>","DOI":"10.3390\/life14010042","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T05:43:15Z","timestamp":1703655795000},"page":"42","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Light-Chain Amyloidosis: The Great Impostor"],"prefix":"10.3390","volume":"14","author":[{"given":"Georgia","family":"Stefani","sequence":"first","affiliation":[{"name":"Department of Hematology, Larisa University Hospital, 41110 Larisa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Kouvata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Larisa University Hospital, 41110 Larisa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Vassilopoulos","sequence":"additional","affiliation":[{"name":"Department of Hematology, Larisa University Hospital, 41110 Larisa, Greece"},{"name":"Cell and Gene Therapy Lab, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"101040","DOI":"10.1016\/j.blre.2023.101040","article-title":"State-of-the-Art Review on AL Amyloidosis in Western Countries: Epidemiology, Health Economics, Risk Assessment and Therapeutic Management of a Rare Disease","volume":"59","author":"Sabinot","year":"2023","journal-title":"Blood Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2141.2001.02999.x","article-title":"Amyloidosis: A Convoluted Story","volume":"114","author":"Kyle","year":"2001","journal-title":"Br. J. Haematol."},{"key":"ref_3","first-page":"45","article-title":"Report on Lardaceous Disease","volume":"11","author":"Wilks","year":"1865","journal-title":"Guys Hosp. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/014107688808101217","article-title":"Lardaceous Disease: Some Early Reports by British Authors (1722\u20131879)","volume":"81","author":"Doyle","year":"1988","journal-title":"J. R. Soc. Med."},{"key":"ref_5","first-page":"206","article-title":"Mollities Ossium, Doubtful Whether Carcinomatous or Syphilitic","volume":"18","author":"Weber","year":"1867","journal-title":"Trans. Pathol. Soc. Lond."},{"key":"ref_6","first-page":"1537","article-title":"Specific Staining of Amyloid by Congo Red [German]","volume":"69","author":"Bennhold","year":"1922","journal-title":"Munch. Med. Wochenschr."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Yakupova, E.I., Bobyleva, L.G., Vikhlyantsev, I.M., and Bobylev, A.G. (2019). Congo Red and Amyloids: History and Relationship. Biosci. Rep., 39.","DOI":"10.1042\/BSR20181415"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"36436","DOI":"10.1074\/jbc.M005698200","article-title":"Alternate Aggregation Pathways of the Alzheimer Beta-Amyloid Peptide. An in Vitro Model of Preamyloid","volume":"275","author":"Huang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5858\/2001-125-0250-CR","article-title":"\u201cCongo\u201d Red: Out of Africa?","volume":"125","author":"Steensma","year":"2001","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.0954-6820.1938.tb17113.x","article-title":"Multiple Myelome","volume":"95","year":"1938","journal-title":"Acta Med. Scand."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archinte.1961.03620030032004","article-title":"\u201cPrimary\u201d Systemic Amyloidosis and Myeloma. Discussion of Relationship and Review of 81 Cases","volume":"107","author":"Kyle","year":"1961","journal-title":"Arch. Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.172.3988.1150","article-title":"Amyloid Fibril Proteins: Proof of Homology with Immunoglobulin Light Chains by Sequence Analyses","volume":"172","author":"Glenner","year":"1971","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.174.4010.712","article-title":"Creation of \u201cAmyloid\u201d Fibrils from Bence Jones Proteins in Vitro","volume":"174","author":"Glenner","year":"1971","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000506617","article-title":"When to Suspect a Diagnosis of Amyloidosis","volume":"143","author":"Vaxman","year":"2020","journal-title":"Acta Haematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1177\/0300060518814337","article-title":"Multiorgan Involvement by Amyloid Light Chain Amyloidosis","volume":"47","author":"Li","year":"2019","journal-title":"J. Int. Med. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/20009666.2021.1915547","article-title":"AL Type Cardiac Amyloidosis: A Devastating Fatal Disease","volume":"11","author":"Nasrullah","year":"2021","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1182\/blood-2021-151675","article-title":"Exploration of the Appropriate NT-Probnp Level for AL Amyloidosis Staging","volume":"138","author":"Kim","year":"2021","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"O87","DOI":"10.1186\/1532-429X-14-S1-O87","article-title":"Patterns of Late Gadolinium Enhancement in 94 Patients with AL or Transthyretin Cardiac Amyloidosis","volume":"14","author":"Dungu","year":"2012","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1148\/rg.2020190069","article-title":"Trends in Diagnostic Imaging of Cardiac Amyloidosis: Emerging Knowledge and Concepts","volume":"40","author":"Oda","year":"2020","journal-title":"RadioGraphics"},{"key":"ref_20","first-page":"665","article-title":"Amyloidosis (AL). Clinical and Laboratory Features in 229 Cases","volume":"58","author":"Kyle","year":"1983","journal-title":"Mayo Clin. Proc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/JBM.S129516","article-title":"The Risk of Renal Disease Is Increased in Lambda Myeloma with Bone Marrow Amyloid Deposits","volume":"8","author":"Kozlowski","year":"2017","journal-title":"J. Blood Med."},{"key":"ref_22","first-page":"2967","article-title":"Renal Involvement in AL Amyloidosis: The Facts, the Promise and the Hope","volume":"24","author":"Ronco","year":"2009","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.\u2014Eur. Ren. Assoc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0002-9343(01)00919-6","article-title":"Primary Systemic Amyloidosis: A Cause of Malabsorption Syndrome","volume":"111","author":"Hayman","year":"2001","journal-title":"Am. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1080\/00365520902783717","article-title":"Primary (AL) Amyloidosis with Gastrointestinal Involvement","volume":"44","author":"Madsen","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF01213300","article-title":"99mTc-HSA-D Scintigraphy in the Diagnosis of Protein-Losing Gastroenteropathy Due to Secondary Amyloidosis","volume":"32","author":"Suzuki","year":"1997","journal-title":"J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/j.1572-0241.2003.07695.x","article-title":"Rapid Intestinal Transit as a Primary Cause of Severe Chronic Diarrhea in Patients with Amyloidosis","volume":"98","author":"Guirl","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.2169\/internalmedicine.2864-19","article-title":"Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency","volume":"58","author":"Guo","year":"2019","journal-title":"Intern. Med. Tokyo Jpn."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/bjh.13156","article-title":"BCSH Committee Guidelines on the Diagnosis and Investigation of AL Amyloidosis","volume":"168","author":"Gillmore","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41408-021-00486-4","article-title":"Comprehensive Review of AL Amyloidosis: Some Practical Recommendations","volume":"11","author":"Bazarbachi","year":"2021","journal-title":"Blood Cancer J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e8771","DOI":"10.1097\/MD.0000000000008771","article-title":"Case Report: One Case of Primary AL Amyloidosis Repeatedly Misdiagnosed as Scleroderma","volume":"96","author":"Sun","year":"2017","journal-title":"Medicine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e240226","DOI":"10.1136\/bcr-2020-240226","article-title":"Unusual Case of Amyloidosis Presenting as a Jejunal Mass","volume":"14","author":"Mohan","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000508022","article-title":"Confirming the Diagnosis of Amyloidosis","volume":"143","author":"Wisniowski","year":"2020","journal-title":"Acta Haematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"22715","DOI":"10.1074\/jbc.M011499200","article-title":"Is Congo Red an Amyloid-Specific Dye?","volume":"276","author":"Khurana","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3324\/haematol.2013.102764","article-title":"Clinical Diagnosis and Typing of Systemic Amyloidosis in Subcutaneous Fat Aspirates by Mass Spectrometry-Based Proteomics","volume":"99","author":"Vrana","year":"2014","journal-title":"Haematologica"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/13506129.2022.2147636","article-title":"Amyloid Nomenclature 2022: Update, Novel Proteins, and Recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee","volume":"29","author":"Buxbaum","year":"2022","journal-title":"Amyloid"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/joim.13169","article-title":"Systemic Amyloidosis from A (AA) to T (ATTR): A Review","volume":"289","author":"Muchtar","year":"2021","journal-title":"J. Intern. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Dugo, K., Bruno, F., Sturiale, V., Brancato, D., Saccone, S., and Federico, C. (2022). Hereditary Transthyretin-Related Amyloidosis: Genetic Heterogeneity and Early Personalized Gene Therapy. Biomedicines, 10.","DOI":"10.3390\/biomedicines10102394"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.rdc.2018.06.004","article-title":"Secondary, AA, Amyloidosis","volume":"44","author":"Papa","year":"2018","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1148\/rg.2020200068","article-title":"Radionuclide Imaging of Cardiac Amyloidosis and Sarcoidosis: Roles and Characteristics of Various Tracers","volume":"40","author":"Hotta","year":"2020","journal-title":"RadioGraphics"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Briasoulis, A., Bampatsias, D., Papamichail, A., Kuno, T., Skoularigis, J., Xanthopoulos, A., and Triposkiadis, F. (2023). Invasive and Non-Invasive Diagnostic Pathways in the Diagnosis of Cardiac Amyloidosis. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10060256"},{"key":"ref_41","first-page":"e000029","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2\u2014Evidence Base and Standardized Methods of Imaging","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"R\u00edos-Tamayo, R., Krsnik, I., G\u00f3mez-Bueno, M., Garcia-Pavia, P., Segovia-Cubero, J., Huerta, A., Salas, C., Silvestre, R.\u00c1., S\u00e1nchez, A., and Manso, M. (2023). AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor. Life, 13.","DOI":"10.3390\/life13071518"},{"key":"ref_43","first-page":"127","article-title":"Light Chain Deposition Disease; There Are Reasons for Confusion","volume":"2","author":"Ardalan","year":"2013","journal-title":"J. Ren. Inj. Prev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/ckj\/sfs062","article-title":"Heavy-Chain Deposition Disease: A Morphological, Immunofluorescence and Ultrastructural Assessment","volume":"5","author":"Rane","year":"2012","journal-title":"Clin. Kidney J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.mayocp.2021.03.012","article-title":"Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update","volume":"96","author":"Muchtar","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3324\/haematol.2019.218859","article-title":"Predicting Survival in Light Chain Amyloidosis","volume":"104","author":"Palladini","year":"2019","journal-title":"Haematologica"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1200\/JCO.2017.76.9554","article-title":"Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time","volume":"36","author":"Sidiqi","year":"2018","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/hemato3010008","article-title":"Monitoring Patients with Light Chain (AL) Amyloidosis during and after Therapy: Response Assessment and Identification of Relapse","volume":"3","author":"Milani","year":"2022","journal-title":"Hemato"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of Organ Involvement and Treatment Response in Immunoglobulin Light Chain Amyloidosis (AL): A Consensus Opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18\u201322 April 2004","volume":"79","author":"Gertz","year":"2005","journal-title":"Am. J. Hematol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1182\/blood-2016-08-730978","article-title":"The Amyloidogenic Light Chain Is a Stressor That Sensitizes Plasma Cells to Proteasome Inhibitor Toxicity","volume":"129","author":"Oliva","year":"2017","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1200\/JCO.20.01285","article-title":"Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis","volume":"38","author":"Kastritis","year":"2020","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13506129.2022.2093635","article-title":"Guidelines for Non-Transplant Chemotherapy for Treatment of Systemic AL Amyloidosis: EHA-ISA Working Group","volume":"30","author":"Wechalekar","year":"2023","journal-title":"Amyloid"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000506760","article-title":"Supportive Care in AL Amyloidosis","volume":"143","author":"Cibeira","year":"2020","journal-title":"Acta Haematol."},{"key":"ref_57","unstructured":"(2023, August 25). Results of the Phase 3 VITAL Study of NEOD001 (Birtamimab) Plus Standard of Care in Patients with Light Chain (AL) Amyloidosis Suggest Survival Benefit for Mayo Stage IV Patients\u2014ScienceDirect. Available online: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S000649711861095X."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood.2020009039","article-title":"Phase 1a\/b Study of Monoclonal Antibody CAEL-101 (11-1F4) in Patients with AL Amyloidosis","volume":"138","author":"Edwards","year":"2021","journal-title":"Blood"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1182\/hematology.2021000305","article-title":"AL Amyloidosis: Untangling New Therapies","volume":"2021","author":"Bal","year":"2021","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7294","DOI":"10.1182\/blood-2022-169688","article-title":"Efficacy and Safety of Belantamab Mafodotin Monotherapy in Patients with Relapsed or Refractory Light Chain Amyloidosis: A Phase 2 Study By the European Myeloma Network","volume":"140","author":"Kastritis","year":"2022","journal-title":"Blood"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Mauro, E., Ferrer-F\u00e0brega, J., Sauri, T., Soler, A., Cobo, A., Burrel, M., Iserte, G., and Forner, A. (2023). New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy. Cancers, 15.","DOI":"10.3390\/cancers15041244"},{"key":"ref_62","unstructured":"(2023, August 25). BCMA-Directed CAR-T HBI0101 Demonstrates Safety and Efficacy in Patients with Light Chain Amyloidosis. Available online: https:\/\/www.cgtlive.com\/view\/bcma-directed-car-t-hbi0101-demonstrates-safety-efficacy-patients-light-chain-amyloidosis."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/14\/1\/42\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:42:24Z","timestamp":1760132544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/14\/1\/42"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,26]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["life14010042"],"URL":"https:\/\/doi.org\/10.3390\/life14010042","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,26]]}}}